0.9% in the laser
group. HL/S was associated with an increased risk of
recurrent incompetence at 6 weeks, neurologic symptoms at 6 weeks, and surgical site infection (RR, 18.47; 95%
CI, 1.01-337.22; RR, 4.73; 95% CI, 2.06-10.85; and RR, 2